You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 273 No. 3, January 18, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure

R. M. Wachter, J. M. Luce, S. Safrin, D. C. Berrios, E. Charlebois and A. A. Scitovsky
Medical Service, San Francisco General Hospital Medical Center.

OBJECTIVE--To determine the costs and outcomes associated with intensive care unit (ICU) admission for patients with acquired immunodeficiency syndrome (AIDS)-related Pneumocystis carinii pneumonia (PCP), and severe respiratory failure. DESIGN--Survival and cost-effectiveness analysis. SETTING--A large municipal teaching hospital serving an indigent population. PATIENTS--Consecutive patients intubated and mechanically ventilated for AIDS, PCP, and respiratory failure from 1981 through 1991 (n = 113). The cohort was separated into three groups for analysis: patients admitted to the ICU in 1981 through 1985 (era I, n = 43), those admitted in 1986 through 1988 (era II, n = 33), and those admitted in 1989 through 1991 (era III, n = 37). MAIN OUTCOME MEASURES--Hospital charges and survival time; cost per year of life saved, using a zero-cost, zero-life assumption. RESULTS--Twenty-eight (25%) of the 113 patients mechanically ventilated for PCP and respiratory failure survived to hospital discharge: six (14%) of 43 in era I, 13 (39%) of 33 in era II, and nine (24%) of 37 in era III (P = .04). Post-ICU admission charges averaged $57,874 for the entire cohort, remaining relatively stable across the three eras. Cost of care for survivors was significantly more expensive than for those dying before discharge. The cost of ICU admission and subsequent hospitalization averaged $174,781 per year of life saved; $305,795 in era I, $94,528 in era II, and $215,233 in era III. Improved survival rates and shorter lengths of ICU stay led to the improved cost-effectiveness in era II, while the opposite trends resulted in worsening cost-effectiveness in recent years. The strongest predictors of hospital mortality in era III were low CD4 cell counts on hospital admission and the development of pneumothorax during mechanical ventilation. CONCLUSIONS--The cost-effectiveness of intensive care for patients with PCP and severe respiratory failure improved during the first 8 years of the AIDS epidemic but fell in recent years such that it is now below that of many accepted medical interventions.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy
Miller et al.
Thorax 2006;61:716-721.
ABSTRACT | FULL TEXT  

Outcome of Critically Ill Human Immunodeficiency Virus-Infected Patients in the Era of Highly Active Antiretroviral Therapy
Khouli et al.
J Intensive Care Med 2005;20:279-285.
ABSTRACT  

Acute Respiratory Failure Due to Pneumocystis Pneumonia in Patients Without Human Immunodeficiency Virus Infection: Outcome and Associated Features
Festic et al.
Chest 2005;128:573-579.
ABSTRACT | FULL TEXT  

Intensive Care of Human Immunodeficiency Virus-infected Patients during the Era of Highly Active Antiretroviral Therapy
Morris et al.
Am. J. Respir. Crit. Care Med. 2002;166:262-267.
ABSTRACT | FULL TEXT  

Can Health Care Costs Be Reduced by Limiting Intensive Care at the End of Life?
LUCE and RUBENFELD
Am. J. Respir. Crit. Care Med. 2002;165:750-754.
FULL TEXT  

Cost and Outcome of Mechanical Ventilation for Life-Threatening Stroke
Mayer et al.
Stroke 2000;31:2346-2353.
ABSTRACT | FULL TEXT  

Improvements in Outcomes of Acute Respiratory Failure for Patients with Human Immunodeficiency Virus-related Pneumocystis carinii Pneumonia
RANDALL CURTIS et al.
Am. J. Respir. Crit. Care Med. 2000;162:393-398.
ABSTRACT | FULL TEXT  

Clinical Course, Prognostic Factors, and Outcome Prediction for HIV Patients in the ICU : The PIP (Pulmonary Complications, ICU Support, and Prognostic Factors in Hospitalized Patients With HIV) Study
Afessa and Green
Chest 2000;118:138-145.
ABSTRACT | FULL TEXT  

Outcomes of Intensive Care for Patients With Human Immunodeficiency Virus Infection
Nickas and Wachter
Arch Intern Med 2000;160:541-547.
ABSTRACT | FULL TEXT  

Determinants of Short- and Long-term Outcome in Patients With Respiratory Failure Caused by AIDS-Related Pneumocystis carinii Pneumonia
Forrest et al.
Arch Intern Med 1999;159:741-747.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.